Naphtheridinone- and pyridooxazinone-pyridone compounds, cardiotonic
申请人:Rhone-Poulenc Rorer Pharmaceuticals Inc.
公开号:US05015638A1
公开(公告)日:1991-05-14
This invention relates to substituted pyridooxazinone and naphtheridone pyridones which are useful as cardiotonic agents for the treatment of congestive heart failure, to methods for increasing cardiac contractility using said compounds, and pharmaceutical compositions including the same.